Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Hanna

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|June 19, 2009
Flight muscle enzymes and metabolic flux rates during hovering flight of the nectar bat, Glossophaga soricina: further evidence of convergence with hummingbirdsR K Suarez, K C Welch, S K Hanna, et al.
Environmental Science. Nano|November 15, 2024
Feasibility of using a standardized <i>Caenorhabditis elegans</i> toxicity test to assess nanomaterial toxicityS K Hanna, G A Cooksey, S Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenograftsM N Kirstein, P J Houghton, P J Cheshire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenograftsW C Zamboni, P J Houghton, J Thompson, et al.
Cancer Chemotherapy and Pharmacology|March 11, 1999
Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell linesW C Zamboni, P J Houghton, J L Hulstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Pharmacokinetics of irinotecan and its metabolites SN-38 and APC in children with recurrent solid tumors after protracted low-dose irinotecanM K Ma, W C Zamboni, K M Radomski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft modelsW C Zamboni, C F Stewart, P J Cheshire, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 1998
Probenecid alters topotecan systemic and renal disposition by inhibiting renal tubular secretionW C Zamboni, P J Houghton, R K Johnson, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology|June 19, 2009
Flight muscle enzymes and metabolic flux rates during hovering flight of the nectar bat, Glossophaga soricina: further evidence of convergence with hummingbirdsR K Suarez, K C Welch, S K Hanna, et al.
Environmental Science. Nano|November 15, 2024
Feasibility of using a standardized <i>Caenorhabditis elegans</i> toxicity test to assess nanomaterial toxicityS K Hanna, G A Cooksey, S Dong, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Relation between 9-aminocamptothecin systemic exposure and tumor response in human solid tumor xenograftsM N Kirstein, P J Houghton, P J Cheshire, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenograftsW C Zamboni, P J Houghton, J Thompson, et al.
Cancer Chemotherapy and Pharmacology|March 11, 1999
Relationship between tumor extracellular fluid exposure to topotecan and tumor response in human neuroblastoma xenograft and cell linesW C Zamboni, P J Houghton, J L Hulstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2000
Pharmacokinetics of irinotecan and its metabolites SN-38 and APC in children with recurrent solid tumors after protracted low-dose irinotecanM K Ma, W C Zamboni, K M Radomski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 14, 1998
Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft modelsW C Zamboni, C F Stewart, P J Cheshire, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 22, 1998
Probenecid alters topotecan systemic and renal disposition by inhibiting renal tubular secretionW C Zamboni, P J Houghton, R K Johnson, et al.
Pageof 1